EED and malignant peripheral nerve sheath tumor: Complete PRC2 loss of function through inactivation of either EED or SUZ12 is observed in a majority of malignant peripheral nerve sheath tumors (MPNST), as well as in a small subset of melanomas and glioblastomas8.